Release Date: 11/09/14 09:49 Summary: Asthma Research Agreement & Capital Raising Price Sensitive: Yes Download Document 71.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%